SLGL
Sol-Gel Technologies Ltd
NASDAQ · Pharmaceuticals
$65.78
+1.08 (+1.67%)
Open$64.20
Previous Close$64.70
Day High$65.78
Day Low$63.38
52W High$14.70
52W Low$8.52
Volume—
Avg Volume619.3K
Market Cap183.25M
P/E Ratio—
EPS$-0.93
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
-81.1% upside
Current
$65.78
$65.78
Target
$12.40
$12.40
$7.31
$12.40 avg
$17.49
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 88.52M | 80.43M | 74.82M |
| Net Income | 26.33M | 27.17M | 21.09M |
| Profit Margin | 29.7% | 33.8% | 28.2% |
| EBITDA | 47.92M | 38.14M | 36.98M |
| Free Cash Flow | 19.52M | 15.33M | 13.15M |
| Rev Growth | +7.8% | -4.6% | -5.6% |
| Debt/Equity | 0.40 | 0.36 | 0.43 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |